Literature DB >> 25770120

Endovascular treatment of intracranial aneurysms using the Pipeline Flex embolization device: a case series of 30 consecutive patients.

M Martínez-Galdámez1, S Pérez1, A Vega2, P Ruiz2, J L Caniego3, E Bárcena3, P Saura4, J C Méndez5, F Delgado6, S Ortega-Gutierrez7, A Romance8, T Diaz8, E Gonzalez9, A Gil9, E Murias10, P Vega10.   

Abstract

BACKGROUND: The Pipeline Flex embolization device has some peculiarities in comparison with the previous generation device. Despite recent reports of the modified delivery system, its safety is still unknown.
OBJECTIVE: To illustrate the intraprocedural and periprocedural complication rate with this new device in 30 consecutive patients.
MATERIAL AND METHODS: Clinical, procedural, and angiographic data, including aneurysm size and location, device or devices used, angiographic and clinical data were analyzed.
RESULTS: 30 patients harboring 30 aneurysms were analyzed. 39 devices were placed properly. Multiple Pipeline embolization devices (PEDs) were used in 7 cases. In 28 devices the distal end opened fully from the beginning with a complete wall apposition. In the remaining 11 devices, distal-end opening of the devices was instant but partial, but fully opened easily after recapture. Among the 30 procedures, recapture and reposition of the Pipeline Flex was performed four times owing to proximal migration/malposition of the device during delivery. Four intraprocedural/periprocedural complications occurred, of which 2 resulted in major complications, with neurologic deficits persisting for longer than 7 days. The 30-day morbidity rate was 6.6%, with no deaths. No aneurysm rupture or parenchymal hemorrhage was seen.
CONCLUSIONS: The Pipeline Flex embolization device allows more precise and controlled deployment than the first-generation device. The number of devices and the complication rate during the learning curve are lower than reported with the first-generation PED. The new delivery system and the resheathing maneuvers do not seem to increase the intraprocedural complication rate in comparison with the first-generation PED. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Aneurysm; Flow Diverter

Mesh:

Year:  2015        PMID: 25770120     DOI: 10.1136/neurintsurg-2015-011669

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  11 in total

1.  Mid-term follow-up of staged bilateral internal carotid artery aneurysm treatment with Pipeline embolization.

Authors:  Juan G Tejada; Gloria Vv Lopez; Jerry Me Koovor; Kalen Riley; Mesha Martinez
Journal:  Interv Neuroradiol       Date:  2019-06-03       Impact factor: 1.610

2.  Treatment of Intracranial Aneurysms With Pipeline Embolization Device: Newer Applications and Technical Advances.

Authors:  Santosh B Murthy; Jharna Shah; Halinder S Mangat; Philip Stieg
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

Review 3.  On Flow Diversion: The Changing Landscape of Intracerebral Aneurysm Management.

Authors:  A A Dmytriw; K Phan; J M Moore; V M Pereira; T Krings; A J Thomas
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-20       Impact factor: 3.825

4.  Unruptured giant intracavernous aneurysms untolerate internal carotid artery occlusion test: Untreated and treated with flow-diversion.

Authors:  Xianli Lv; Jianjun Yu; Ting Liao; Jin Wang; Guihuai Wang
Journal:  Neuroradiol J       Date:  2020-01-17

5.  Mid-term and long-term follow-up of intracranial aneurysms treated by the p64 Flow Modulation Device: a multicenter experience.

Authors:  Francesco Briganti; Giuseppe Leone; Lorenzo Ugga; Mariano Marseglia; Antonio Macera; Andrea Manto; Luigi Delehaye; Maurizio Resta; Mariachiara Resta; Nicola Burdi; Nunzio Paolo Nuzzi; Ignazio Divenuto; Ferdinando Caranci; Mario Muto; Domenico Solari; Paolo Cappabianca; Francesco Maiuri
Journal:  J Neurointerv Surg       Date:  2016-07-20       Impact factor: 5.836

6.  Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study.

Authors:  Mario Martínez-Galdámez; Saleh M Lamin; Konstantinos G Lagios; Thomas Liebig; Elisa F Ciceri; Rene Chapot; Luc Stockx; Swarupsinh Chavda; Christoph Kabbasch; Giuseppe Farago; Hannes Nordmeyer; Thierry Boulanger; Mariangela Piano; Edoardo P Boccardi
Journal:  J Neurointerv Surg       Date:  2017-02-20       Impact factor: 5.836

7.  Internal Carotid Artery Reconstruction with a "Mega Flow Diverter": First Experience with the 6×50 mm DERIVO Embolization Device.

Authors:  Mario Martínez-Galdámez; Claudio Rodríguez; Antonio Hermosín; Eduardo Crespo-Vallejo; Gonzalo Monedero; Juan Chaviano; Bin Zheng
Journal:  Neurointervention       Date:  2018-08-31

8.  The Evolution of Flow-Diverting Stents for Cerebral Aneurysms; Historical Review, Modern Application, Complications, and Future Direction.

Authors:  Dong-Seong Shin; Christopher P Carroll; Mohammed Elghareeb; Brian L Hoh; Bum-Tae Kim
Journal:  J Korean Neurosurg Soc       Date:  2020-02-27

Review 9.  Bailout Strategies and Complications Associated with the Use of Flow-Diverting Stents for Treating Intracranial Aneurysms.

Authors:  Fawaz Al-Mufti; Eric R Cohen; Krishna Amuluru; Vikas Patel; Mohammad El-Ghanem; Rolla Nuoman; Neil Majmundar; Neha S Dangayach; Philip M Meyers
Journal:  Interv Neurol       Date:  2018-10-16

10.  Ex-vivo release of Pipeline Embolization Device polytetrafluoroethylene (PTFE) sleeves for improved distal landing zone accuracy in-vivo: A technical note.

Authors:  Christoph J Griessenauer; Raghav Gupta; Justin Moore; Ajith J Thomas; Christopher S Ogilvy
Journal:  Interv Neuroradiol       Date:  2016-07-28       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.